ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1264

Residential Proximity to Highways, DNA Methylation and Systemic Lupus Erythematosus

Cristina Lanata1, Renuka Nayak2, Joanne Nitiham1, Kimberly Taylor3, Lisa F. Barcellos4, Sharon A. Chung5 and Lindsey A. Criswell6,7, 1Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 2Department of Medicine, UCSF, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA, 3University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 4Genetic Epidemiology and Genomics Laboratory, University of California, Berkeley, Berkeley, CA, 5School of Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 6Rheumatology, UCSF, SAN FRANCISCO, CA, 7Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: DNA Methylation, SLE and environmental factors

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Genetics, Genomics and Proteomics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic lupus erythematosus (SLE) is a heterogeneous disease characterized by autoantibody formation in which multiple genetic, epigenetic and environmental risk factors have been implicated. We previously demonstrated that methylation levels differ significantly among SLE patients according to auto-antibody status and presence/absence of lupus nephritis. The study of epigenetics provides a mechanistic bridge to understand the effects of environmental exposures with disease risk and outcome. Air pollution has been linked not only to an increase in overall mortality but also to an increased incidence of rheumatoid arthritis. There are few studies evaluating air pollution and SLE development and outcomes.  However, anti-dsDNA antibody titers have been associated with high levels of air particulate matter. The goal of this study was to evaluate methylation differences in relation to residential proximity to highways in patients with SLE. 

Methods:

We studied 307 Caucasian females with SLE, all non-smokers, who were previously enrolled in a Lupus Genetics Project.  Residence at the time of blood draw was recorded and geocoded.  The distance to the nearest roads from the geocoded locations were calculated for the four major Tele Atlas Feature Class Codes (FCC) road classes. The Geographic Data Technology, Inc. (GDT) road network data were used for these calculations.  Genome-wide methylation profiling was performed using the Illumina Infinium HumanMethylation 450 BeadChip. After quality control measures 467,314 CpG sites were analyzed. 

Results:

Patients residing within a 300 meter radius from a major highway were defined as at high risk for significant hazardous health outcomes1. Thirty-eight patients (12.4%) were residing in a high risk area. Multivariate analysis did not reveal any statistically significant association between proximity to highways and disease phenotypes, however there was a trend for higher incidence of malar rash (OR 2.4, CI[1.1, 5]) and photosensitivity (OR 2.7, CI[1.2, 5.9]). Analysis of genome-wide methylation data revealed 3 methylation sites that were significantly hypomethylated in patients who resided in a high risk zone (P value <1.7 E-07).  These three sites belonged to a single gene, UBE2U, which encodes one of the E2 enzymes involved in the ubiquitination of proteins and histones, as well as DNA repair.  Genome wide association studies (GWAS) in SLE have identified a risk variant at UBE2L3, also an E2 ubiquitination enzyme. In a large ongoing GWAS marked overexpression of UBE2L3 was seen in plasmablasts of patients of SLE with an associated upregulation of NF-κB.

Conclusion:

Hypomethylation of UBE2U was associated with residing close to a highway in our cohort of SLE patients.  To our knowledge, this study represents the first genome-wide assessment of DNA methylation in relationship to residential proximity to highways. Additional work is warranted to confirm these findings, examine other potentially relevant exposures, and determine whether these epigenetic changes are associated with SLE severity and outcome.

1.        Residential proximity to major highways – United States, 2010. MMWR Surveill Summ. 2013;62 Suppl 3:46-50.


Disclosure: C. Lanata, None; R. Nayak, None; J. Nitiham, None; K. Taylor, None; L. F. Barcellos, None; S. A. Chung, None; L. A. Criswell, None.

To cite this abstract in AMA style:

Lanata C, Nayak R, Nitiham J, Taylor K, Barcellos LF, Chung SA, Criswell LA. Residential Proximity to Highways, DNA Methylation and Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/residential-proximity-to-highways-dna-methylation-and-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/residential-proximity-to-highways-dna-methylation-and-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology